as 10-28-2024 4:00pm EST
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
Founded: | 1969 | Country: | United States |
Employees: | N/A | City: | NEWPORT BEACH |
Market Cap: | 149.7M | IPO Year: | N/A |
Target Price: | $16.67 | AVG Volume (30 days): | 222.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | -0.13 | EPS Growth: | N/A |
52 Week Low/High: | $4.95 - $14.28 | Next Earning Date: | 11-06-2024 |
Revenue: | $585,049,000 | Revenue Growth: | 2.73% |
Revenue Growth (this year): | -0.29% | Revenue Growth (next year): | 4.69% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ROSENBLOOM KEITH M | AVD | Director | Aug 30 '24 | Buy | $5.92 | 136,492 | $790,844.08 | 1,168,682 | |
ROSENBLOOM KEITH M | AVD | Director | Aug 29 '24 | Buy | $5.74 | 16,480 | $94,595.20 | 1,168,682 | |
Eilers Peter | AVD | See Remarks | Aug 29 '24 | Sell | $5.80 | 5,000 | $29,000.00 | 42,905 | |
WINTEMUTE ERIC G | AVD | Chairman | Aug 29 '24 | Sell | $5.73 | 100,000 | $571,969.00 | 897,027 | |
ROSENBLOOM KEITH M | AVD | Director | Aug 28 '24 | Buy | $5.66 | 33,555 | $189,921.30 | 1,168,682 |
AVD Breaking Stock News: Dive into AVD Ticker-Specific Updates for Smart Investing
GuruFocus.com
20 days ago
Zacks
25 days ago
Zacks
a month ago
Zacks
a month ago
MT Newswires
2 months ago
Simply Wall St.
2 months ago
Insider Monkey
2 months ago
MT Newswires
2 months ago
The information presented on this page, "AVD American Vanguard Corporation ($0.10 Par Value) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.